These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus. Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884 [TBL] [Abstract][Full Text] [Related]
23. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers. Kim MS; Choi CY; Kim JM; Chang HR; Woo HY Br J Ophthalmol; 2008 Nov; 92(11):1518-21. PubMed ID: 18782802 [TBL] [Abstract][Full Text] [Related]
24. Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing. Stevens JD; Matheson MM Br J Ophthalmol; 1992 Jan; 76(1):36-8. PubMed ID: 1739689 [TBL] [Abstract][Full Text] [Related]
25. Microbial Cross-contamination in Multidose Eyedrops: The Impact of Instillation Angle and Bottle Geometry. da Costa AX; Yu MCZ; de Freitas D; Cristovam PC; LaMonica LC; Dos Santos VR; Gomes JAP Transl Vis Sci Technol; 2020 Jun; 9(7):7. PubMed ID: 32832214 [TBL] [Abstract][Full Text] [Related]
26. [Bacterial contamination of eyedrops in clinical use]. Raynaud C; Laveran H; Rigal D; Bonicel P J Fr Ophtalmol; 1997; 20(1):17-24. PubMed ID: 9099279 [TBL] [Abstract][Full Text] [Related]
27. Microbial contamination of preservative free eye drops in multiple application containers. Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520 [TBL] [Abstract][Full Text] [Related]
28. The shelf life of antimicrobial ear drops. Clark MP; Pangilinan L; Wang A; Doyle P; Westerberg BD Laryngoscope; 2010 Mar; 120(3):565-9. PubMed ID: 20013841 [TBL] [Abstract][Full Text] [Related]
29. Patient reliability in the administration of topical ocular medication. Cheng CL; Chee SP; Tan DT Singapore Med J; 2001 Jun; 42(6):252-4. PubMed ID: 11547961 [TBL] [Abstract][Full Text] [Related]
30. Mass variability in drops of multidose eyedrops: a quality and reliability study. Costa AXD; Cristovam PC; Covre JL; Zorat Yu MC; LaMonica LC; Gomes JÁP; Santos VRD Arq Bras Oftalmol; 2021; 84(6):582-586. PubMed ID: 34431879 [TBL] [Abstract][Full Text] [Related]
31. Preservative efficacy in cefuroxime and ceftazidime eye drop formulations. Barnes AR; Nash S J Clin Pharm Ther; 1994 Oct; 19(5):327-32. PubMed ID: 7806604 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial activity of zinc oxide particles on five micro-organisms of the Challenge Tests related to their physicochemical properties. Pasquet J; Chevalier Y; Couval E; Bouvier D; Noizet G; Morlière C; Bolzinger MA Int J Pharm; 2014 Jan; 460(1-2):92-100. PubMed ID: 24211859 [TBL] [Abstract][Full Text] [Related]
34. A model for quantifying difficulty in squeezing eyedrops from their containers. Nesher R; Ezra-Nimni O; Shumla E; Gur J; Hamisha S; Nesher G Arch Ophthalmol; 2007 Aug; 125(8):1114-7. PubMed ID: 17698760 [TBL] [Abstract][Full Text] [Related]
35. Microbial contamination of medications used to treat glaucoma. Geyer O; Bottone EJ; Podos SM; Schumer RA; Asbell PA Br J Ophthalmol; 1995 Apr; 79(4):376-9. PubMed ID: 7742288 [TBL] [Abstract][Full Text] [Related]
36. Using multidose eyedrops in a health care setting: a policy and procedural approach to safe and effective treatment of patients. Jensen MK; Nahoopii R; Johnson B JAMA Ophthalmol; 2014 Dec; 132(12):1476-9. PubMed ID: 25188508 [TBL] [Abstract][Full Text] [Related]
37. [Studies on bacteriologic contamination of potassium chloride solution 25% in multidose containers regularly used on hospital wards]. Schramm G; Bianchi S Schweiz Med Wochenschr; 1982 Aug; 112(31-32):1099-100. PubMed ID: 6753141 [TBL] [Abstract][Full Text] [Related]
38. Preservative efficacy screening of pharmaceutical formulations using ATP bioluminescence. Kramer M; Suklje-Debeljak H; Kmetec V Drug Dev Ind Pharm; 2008 May; 34(5):547-57. PubMed ID: 18473237 [TBL] [Abstract][Full Text] [Related]
39. Growth of four microorganisms in polyethylene glycol-electrolyte lavage solution. Akly TS; DiPiro JT; Steele JC; Kemp GA Am J Hosp Pharm; 1986 Dec; 43(12):3013-6. PubMed ID: 3544827 [TBL] [Abstract][Full Text] [Related]
40. The effect of low density polyethylene containers on some hospital-manufactured eyedrop formulations. II. Inhibition of the sorption of phenylmercuric acetate. Aspinall JE; Duffy TD; Taylor CG J Clin Hosp Pharm; 1983 Sep; 8(3):233-40. PubMed ID: 6630562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]